0001213900-19-017904.txt : 20190912 0001213900-19-017904.hdr.sgml : 20190912 20190912211536 ACCESSION NUMBER: 0001213900-19-017904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190911 FILED AS OF DATE: 20190912 DATE AS OF CHANGE: 20190912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowdell Mark William CENTRAL INDEX KEY: 0001767037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 191091436 MAIL ADDRESS: STREET 1: THE OAK, WLX ROAD CITY: BEAUMONT STATE: X0 ZIP: CO16 0AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2019-09-11 0 0001711754 Inmune Bio, Inc. INMB 0001767037 Lowdell Mark William C/O INMUNE BIO INC., 1200 PROSPECT STREET, SUITE 525 LA JOLLA CA 92037 0 1 1 0 Chief Scientific Officer Common Stock 2019-09-11 4 P 0 2918 6.2298 A 1506251 D The Reporting Person purchased an aggregate of 2,918 shares of the Registrant's common stock on September 11, 2019 in an open market transaction. /s/ Mark Lowdell 2019-09-12